Fluicell AB

Fluicell AB

2.12
EUR
0.00
(0.00%)
0.18EPS
14.46P/E
3.65MMarket Cap
Feb 19Next Earn

Total Valuation

EUR

As of June 30, 2026, Fluicell AB carries a market capitalization of 3.65M, placing it among publicly traded companies globally. Its enterprise value stands at 3.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.65M
Enterprise Value3.83M

Important Dates

Fluicell AB's next confirmed earnings release is scheduled for February 19, 2027.

Earnings Date2/19/2027

Share Statistics

As of June 30, 2026, Fluicell AB has 1.37M shares outstanding.

Shares Outstanding1.37M

Valuation Ratios

As of June 30, 2026, Fluicell AB trades at a trailing price-to-earnings ratio of 14.46. The price-to-sales ratio is 2.20, and the price-to-book ratio stands at 2.46.

PE Ratio14.46
PS Ratio2.20
PB Ratio2.46
P/TBV Ratio11.07
P/FCF Ratio-242.36
P/OCF Ratio-242.36

Enterprise Valuation

As of June 30, 2026, Fluicell AB trades at an EV/EBITDA multiple of 14.43 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.30 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 16.30 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.83M versus a market cap of 3.65M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.30
EV / EBITDA14.43
EV / EBIT16.30

Financial Position

As of June 30, 2026, Fluicell AB maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.14, indicating elevated leverage, while an interest coverage ratio of 20.15 demonstrates strong ability to service its debt obligations.

Current Ratio1.40
Debt / Equity12.14
Debt / EBITDA0.68
Interest Coverage20.15

Financial Efficiency

EUR

Over the twelve months ended June 30, 2026, Fluicell AB posted a return on equity (ROE) of 18.57, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.38 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 12.76, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 18.32, useful for judging operating efficiency across full business cycles. The company generates approximately 147,967.05 in revenue per employee across its workforce of 11.25, a quick read on workforce productivity versus industry peers. Inventory turnover of -1.69 indicates how many times Fluicell AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)18.57
Return on Assets (ROA)12.76
Return on Invested Capital (ROIC)15.38
Return on Capital Employed (ROCE)18.32
Revenue Per Employee147,967.05
Employee Count11.25
Inventory Turnover-1.69

Stock Price Statistics

EUR

As of the close on November 17, 2026, Fluicell AB's stock has gained approximately 89.29% over the past 52 weeks. The 50-day moving average sits at 2.58, while the 200-day moving average is 2.35.

52-Week Price Change89.29%
50-Day Moving Average2.58
200-Day Moving Average2.35

Income Statement

EUR

Over the twelve months ended June 30, 2026, Fluicell AB generated 1.66M in revenue and converted that into 252,700.81 in net income, yielding earnings per share of 0.18. EBITDA reached 265,611.21, while operating income came in at 235,095.72.

Revenue1.66M
Gross Profit2.11M
Operating Income235,095.72
Pretax Income252,700.81
Net Income252,700.81
EBITDA265,611.21
EBIT235,095.72
Earnings Per Share (EPS)0.18

Balance Sheet

EUR

As of June 30, 2026, Fluicell AB holds 2,708.48 in cash and equivalents against 180,565.07 in total debt, resulting in a net debt position of 177,856.59. Total book value stands at 1.49M, with working capital of 310,842.76 providing operational flexibility.

Cash & Cash Equivalents2,708.48
Total Debt180,565.07
Net Debt177,856.59
Equity (Book Value)1.49M
Book Value Per Share1.08
Working Capital310,842.76

Cash Flow

EUR

Fluicell AB produced -15,077.18 in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-15,077.18
Free Cash Flow-15,077.18
FCF Per Share-0.01

Margins

Over the twelve months ended June 30, 2026, Fluicell AB posted a gross margin of 126.70, reflecting its pricing power and cost economics. The operating margin of 14.12 and net profit margin of 15.18 provide insight into operational efficiency.

Gross Margin126.70
Operating Margin14.12
Pretax Margin15.18
Profit Margin15.18
EBITDA Margin15.96

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.41: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.94, meaning Fluicell AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-4.94
FCF Yield-0.41

Stock Splits

Fluicell AB's most recent stock split took place on March 26, 2025 with a 350:1 split ratio.

Last Split Date3/26/2025
Split Ratio350:1

Scores

As of June 30, 2026, Fluicell AB has an Altman Z-Score of -9.95, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.95